This course is geared towards those who want to learn more about the clinical applications and molecular basis of ketamine. You will learn about the dose ranges, indications, contraindications, and concomitant medications of the psychedelic medicine. You will also learn about some fundamental pharmacology and neurobiology as it relates to the administration of psychedelic medicines in psychedelic-assisted therapy.
This course is open to both regulated and non-regulated providers, as well as empowered individuals looking to better understand psychedelic medicines and their healing potential.
The content developed for this course is based on current literature and research and analyzed through the lens of trauma and violence-informed care and through commitments to social justice, equity, dignity, inclusion, cultural safety, and humility.
This course can be completed at your own pace whenever it is most convenient for you, however the course must be completed within 1 year of your registration date. If the course is not completed after 1 year, you will not be eligible for a refund, and you will need to re-register.
This program is not yet approved under the National Board for Certified Counsellors (NBCC) as the application is still currently under review.
This course can be completed at your own pace. It will take approximately 4 hours to complete and must be completed within 1 year of registration.
After the course, you’ll be able to:
We will begin the course by learning about some foundational concepts of neurobiology and pharmacology. While these are both very large domains of knowledge, we will focus on some key concepts to provide some important context to themes discussed later in the course.
In this module, you will learn about the molecular structure of ketamine. We will also explore a brief history and the current legal status of ketamine.
In this module, we will be looking at ketamine’s pharmacodynamics or, in other words, the effects that ketamine has on the body as well as the pharmacokinetics, or how ketamine is absorbed and metabolized by the body.
We will be looking at expected and possible adverse effects (according to the dose range), contraindications, and concomitant medications. We will also be looking at the important role of harm reduction when working with clients in a ketamine-assisted therapy setting.
Yes absolutely. This course is open to anyone looking to learn more about the evidence, molecular basis, and healing potential of psychedelic medicines. This would also be helpful if you are looking to take this medicine in a clinical setting.
Yes – for 4 hours.
Yes, just be mindful of the time zones! Please also note that daylight saving time in North America typically comes into effect on different dates than some other parts of the world.
Please consult the Numinus Training Policies for more information about our policies.
Yes, this course is recognized by the following organizations for continuing education credit.
Canadian Psychological Association
Canadian Counselling and Psychotherapy Association
L’Ordre des psychologues du Québec
Numinus Wellness has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7360. Programs that do not qualify for NBCC credit are clearly identified. Numinus Wellness is solely responsible for all aspects of the programs.
We’re happy to help. Send us an e-mail at email@example.com.